Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
17.95
-1.27 (-6.61%)
At close: May 11, 2026, 4:00 PM EDT
18.25
+0.30 (1.67%)
After-hours: May 11, 2026, 7:18 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
United States Revenue
352.03M365.00M365.05M
United States Revenue Growth
-3.55%-0.01%3.88%
China Revenue
65.54M58.35M58.24M
China Revenue Growth
12.34%0.18%11.72%
United Kingdom Revenue
39.89M35.39M27.20M
United Kingdom Revenue Growth
12.73%30.08%2.04%
Rest of Europe Revenue
110.16M107.37M95.15M
Rest of Europe Revenue Growth
2.60%12.84%9.14%
Asia Pacific/ Other Revenue
28.70M27.71M27.79M
Asia Pacific/ Other Revenue Growth
3.57%-0.29%-18.50%
Revenue (Total)
596.33M593.82M573.45M
Revenue (Total) Growth
0.42%3.55%3.98%

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Sample Management Solutions Revenue
326.00M324.59M318.90M
Sample Management Solutions Revenue Growth
0.43%1.79%5.18%
Multiomics Revenue
270.33M269.23M254.55M
Multiomics Revenue Growth
0.41%5.77%2.52%
Revenue (Total)
596.33M593.82M573.45M
Revenue (Total) Growth
0.42%3.55%3.98%

Revenue Breakdown 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Multiomics Revenue
270.33M269.23M254.55M
Multiomics Revenue Growth
0.41%5.77%2.52%
Core Products Revenue
191.87M197.63M196.50M
Core Products Revenue Growth
-2.92%0.57%2.31%
Sample Repository Solutions Revenue
134.13M126.96M122.39M
Sample Repository Solutions Revenue Growth
5.64%3.73%10.14%
Revenue (Total)
596.33M593.82M573.45M
Revenue (Total) Growth
0.42%3.55%3.98%

Adjusted EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Sample Management Solutions Adjusted Operating Income
28.06M27.55M11.11M
Sample Management Solutions Adjusted Operating Income Growth
1.83%148.06%-
Multiomics Adjusted Operating Income
-18.52M-11.94M-7.73M
Operating Income (Total)
-172.37M-26.84M-51.28M

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Organic Revenue Growth
3.00%-2.00%
Updated May 8, 2026. Data Source: Fiscal.ai.